NCT02058927
- Conditions
- Infections, Measles, Mononegavirales Infections, +4 more
- Locations
-
- Centre for Infectious Disease Research in Zambia Lusaka, Zambia
Clinical trial condition
Paramyxoviridae Infections
Explore clinical trials studying Paramyxoviridae Infections. Study availability and eligibility vary by location and protocol.
354 public trials
28 recruiting studies
Paramyxoviridae Infections trial results
NCT01188343
- Conditions
- Arbovirus Infections, Brain Diseases, Central Nervous System Diseases, +31 more
- Locations
-
- Taichung, Taiwan
- Taipei, Taiwan
- Taoyuan, Taiwan
NCT00313950
- Conditions
- Digestive System Diseases, Enterovirus Infections, Hepatitis, +21 more
- Locations
-
- Izmir, Turkey (Türkiye)
NCT00129766
- Conditions
- Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
- Locations
-
- University Of Alabama At Birmingham Birmingham, Alabama, United States
- Alabama Neonatal Medicine OC Pike Road, Alabama, United States
- Maricopa Medical Center Phoenix, Arizona, United States
- Central Arkansas Pediatric Clinic, PA Benton, Arkansas, United States
Completed
Surveillance Study of Respiratory Syncytial Virus Infection (RSV) in Subjects < 24 Months of Age
NCT01754428
- Conditions
- Infections, Mononegavirales Infections, Paramyxoviridae Infections, +4 more
- Locations
-
- University of Alabama at Birmingham Birmingham, Alabama, United States
- Arkansas Children's Hospital/University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
- University of Colorado Denver/Children's Hospital Colorado Denver, Colorado, United States
- Pediatrics & Adolescent Medicine, P.A. Marietta, Georgia, United States
NCT01466062
- Conditions
- Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
- Locations
-
- Site Reference ID/Investigator# 56847 Hyōgo, Japan
- Site Reference ID/Investigator# 56845 Shimotsuke, Japan
- Site Reference ID/Investigator# 56842 Tokyo, Japan
- Site Reference ID/Investigator# 56844 Tokyo, Japan
Completed
Serological Study in Children 12 to 23 Months Vaccinated With MMR (Measles, Mumps and Rubella)
NCT01874457
- Conditions
- Infections, Measles, Mononegavirales Infections, +14 more
- Locations
-
- Bio-Manguinhos/Fiocruz Rio de Janeiro, Brazil
NCT01801293
- Conditions
- Infections, Mononegavirales Infections, Paramyxoviridae Infections, +5 more
- Locations
-
- Investigational Site Madison, Wisconsin, United States
Completed
Safety and Immune Response of Novartis MenACWY-CRM Conjugate Vaccine When Given to Healthy Toddlers
NCT00626327
- Conditions
- Bacterial Infections, Bacterial Infections and Mycoses, Chickenpox, +26 more
- Locations
-
- Site 85 - Birmingham Pediatric Associates, 806 St. Vincent's Drive Birmingham, Alabama, United States
- Site 86 - Southeastern Pediatrics Associate, 364 Honeysuckle Road Dothan, Alabama, United States
- Site 00 - Veritas Research LLC/ Stabler Clinic, 300 North College Street, Greenville, Alabama, United States
- Site 42 - Drug Research and Analysis Corporation, 1758 Parkplace, Suite 200 Montgomery, Alabama, United States
NCT00316264
- Conditions
- Chronic Lung Disease and <= 24 Months of Age or, Female Urogenital Diseases and Pregnancy Complications, Infections, +12 more
- Locations
-
- Department of Paediatrics and Child Health, The Canberra Hospital Garran, Australian Capital Territory, Australia
- Neonatalogy John Hunter Hospital New Lambton Heights, New South Wales, Australia
- Caboolture Clinical Research Caboolture, Queensland, Australia
- University of Queensland, Royal Children's Hospital Herston, Queensland, Australia